# Effect of Lorcaserin on Cannabis Withdrawal and Self-administration

> **NCT03253926** · PHASE1,PHASE2 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 15 (actual)

## Conditions studied

- Cannabis Use

## Interventions

- **DRUG:** Lorcaserin
- **DRUG:** Placebo
- **DRUG:** Marijuana

## Key facts

- **NCT ID:** NCT03253926
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-05
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03253926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03253926, "Effect of Lorcaserin on Cannabis Withdrawal and Self-administration". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03253926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*